|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Genetic background in nonalcoholic fatty liver disease: A comprehensive review显示文摘In the Western world, nonalcoholic fatty liver disease(NAFLD) is considered as one of the most significant liver diseases of the twenty-first century. Its development is certainly driven by environmental factors, but it is also regulated by genetic background. The role of heritability has been widely demonstratedby several epidemiological, familial, and twin studies and case series, and likely reflects the wide interindividual and inter-ethnic genetic variability in systemic metabolism and wound healing response processes. Consistent with this idea, genome-wide association studies have clearly identified Patatin-like phosholipase domain-containing 3 gene variant I148 M as a major player in the development and progression of NAFLD. More recently, the transmembrane 6 superfamily member 2 E167 K variant emerged as a relevant contributor in both NAFLD pathogenesis and cardiovascular outcomes. Furthermore, numerous casecontrol studies have been performed to elucidate the potential role of candidate genes in the pathogenesis and progression of fatty liver, although findings are sometimes contradictory. Accordingly, we performed a comprehensive literature search and review on the role of genetics in NAFLD. We emphasize the strengths and weaknesses of the available literature and outline the putative role of each genetic variant in influencing susceptibility and/or progression of the disease. | Fabio Salvatore Macaluso Marcello Maida Salvatore Petta | 2015 | World Journal of Gastroenterology2015，21，39： | 14 |
| 2 | Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis显示文摘 | Erica Villa Calogero Cammà Marco Marietta Monica Luongo Rosina Critelli Stefano Colopi Cristina Tata Ramona Zecchini Stefano Gitto Salvatore Petta Barbara Lei Veronica Bernabucci Ranka Vukotic Nicola De Maria Filippo Schepis Aimilia Karampatou Cristian Ca | 2012 | Gastroenterology2012，，5： | 5 |
| 3 | Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease显示文摘 | Elena Centis Simona Moscatiello Elisabetta Bugianesi Stefano Bellentani Anna Ludovica Fracanzani Simona Calugi Salvo Petta Riccardo Dalle Grave Giulio Marchesini | 2012 | Journal of Hepatology2012，，： | 5 |
| 4 | Non-alcoholic fatty liver disease pathogenesis: The present and the future显示文摘 | S. Petta C. Muratore A. Craxì | 2009 | Digestive and Liver Disease2009，，9： | 2 |
| 5 | IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease显示文摘 | Salvatore Petta Stefania Grimaudo Calogero Cammà Daniela Cabibi Vito Di Marco Giusalba Licata Rosaria Maria Pipitone Antonio Craxì | 2012 | Journal of Hepatology2012，，6： | 2 |
| 6 | PNPLA 3 rs738409 I748M is associated with steatohepatitis in 434 non‐obese subjects with hepatitis C显示文摘 | S. Petta E. Vanni E. Bugianesi C. Rosso D. Cabibi C. Cammà V. Di Marco M. Eslam S. Grimaudo F. S. Macaluso D. McLeod R. M. Pipitone M. L. Abate A. Smedile J. George A. Craxì | 2015 | Aliment Pharmacol Ther2015，，10： | 2 |
| 7 | Statin use and non-alcoholic steatohepatitis in at risk individuals显示文摘 | Paola Dongiovanni Salvatore Petta Ville Mannisto Rosellina Margherita Mancina Rosaria Pipitone Vesa Karja Marco Maggioni Pirjo Kakela Olov Wiklund Enrico Mozzi Stefania Grimaudo Dorota Kaminska Raffaela Rametta Antonio Craxi Silvia Fargion Valerio Nobili | 2015 | Journal of Hepatology2015，，3： | 2 |
| 8 | Prophylactic quadrivalent human papillomavirus (types 6,11,16,and 18) L1 virus-like particle vaccine in young women:a randomised double-blind placebo -controlled multicentre phase Ⅱ efficacy trial显示文摘 | Villa LL Costa RL Petta CA | 2005 | Lancet Oncol2005，6，5： | 1 |
| 9 | Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis显示文摘 | Petta CA Ferriani RA Abrao MS | 2005 | Hum Reprod2005，20，7： | 1 |
| 10 | High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up显示文摘 | Villa LL Costa RL Petta CA | 2006 | Br J Cancer2006，95，11： | 1 |
| 11 | RAD 001(everolimus) prevents mTOR and Akt late re - activation inresponse to imatinib in chronic myeloid leukemia显示文摘 | MANCINI M PETTA S MARTINELU G | 2010 | J Cell Bio2010，109，2： | 1 |
| 12 | Coherent manipulation of coupled electron spins in semiconductor quantum dots显示文摘 | Petta J R Johnson A C Taylor J M | 2005 | Science2005，309，： | 1 |
| 13 | Prophylactie quadrivalent hu- man papillomavirus(types 6,11,16, and 18) L1 virus - like particle vaccine in young women; A randomised double - blind placebo - controlled multicentre phase Ⅱ efficacy trial 显示文摘 | Villa LL Costa RL Petta CA | 2005 | Lancet Oncal2005，6，5： | 1 |
| 14 | High sustained efficacy of a prophylactic quadrivalent human papillomavims types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up 显示文摘 | Villa LL Costa RL Petta CA | 2006 | Br J Cancer2006，95，11： | 1 |
| 15 | Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) Llvirus-like particle vaccine in young women : a randomized double-blind placebo-controlled multicentre phase Ⅱ efficacy trial 显示文摘 | Villa LL Costa RL Petta CA | 2005 | Lancet Oneol2005，6，5： | 1 |
| 16 | Non-alcoholic fatty liver disease pathogenesis: the present and the future 显示文摘 | PETTA S MURATORE C CRAX] A | 2009 | Dig Liver Dis2009，41，9： | 1 |
| 17 | Prophylactic quadrivalent human papillomavirns (types6,11,16,and 18) L1 virus-like particle vaccine in young women:a randomized double-blind placebocontrolled multicentre phase Ⅱ efficacy trial显示文摘 | Costa RL Petta CA | 2005 | The Lancet oncology2005，6，5： | 1 |
| 18 | Vascular endothelial growth factor concentrations in the serum and peritoneal fluid of women with endometriosis 显示文摘 | Pupo-Nogueira A de Oliveira R M Petta C A | 2007 | Int J GynaecolObstet2007，99，1： | 1 |
| 19 | Enlarged ovarian follicles in users of a levonorgestrel-releasing intrauterine system and contraceptive implant显示文摘 | Bahamondes L Hidalgo M Petta CA | 2003 | J Reprod Med2003，48，8： | 1 |
| 20 | Randomized clinical trial of a levonorgestrel releasing intrauterine system and a depot GnRH an- alogue for the treatment of chronic pelvic pain in women with endome- triosis 显示文摘 | Petta CA Ferriani RA Abrao MS | 2005 | Hum Reprod2005，20，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员